<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/supn" ></link>
<id>urn:uuid:b7e6af2b-3d0c-5105-024e-d08a97b266c9</id>
<updated>2013-05-23T06:04:19-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>SUPN: BIGHAM MICHAEL (DIR) Bought (B) 35k Shares of SUPERNUS PHARMACEUTICALS INC for $5.17-$5.65 on 3/20-3/22</title>
<link href="http://www.insiderinsights.com/company/supn/supernus-pharmaceuticals-inc/id-2396620" ></link>
<id>urn:uuid:0d1dfd41-b36a-2f5b-6188-83ecfd1e832c</id>
<updated>2013-03-26T16:33:14-04:00</updated>
<summary type="html" ><![CDATA[SUPERNUS PHARMACEUTICALS INC (SUPN). Recent Price: $6.00. Mkt Cap:185.9mm. 10D Vol: 900k]]></summary>
</entry>
<entry>
<title>SUPN: SIEBERT JOHN M (DIR) Bought (B) 3k Shares of SUPERNUS PHARMACEUTICALS INC for $5.50 on 3/21</title>
<link href="http://www.insiderinsights.com/company/supn/supernus-pharmaceuticals-inc/id-2395707" ></link>
<id>urn:uuid:5703daac-309d-0816-7172-148fcdd8efd5</id>
<updated>2013-03-25T15:17:25-04:00</updated>
<summary type="html" ><![CDATA[SUPERNUS PHARMACEUTICALS INC (SUPN). Recent Price: $6.00. Mkt Cap:185.9mm. 10D Vol: 900k]]></summary>
</entry>
<entry>
<title>SUPN: KHATTAR JACK A (PR,CEO,DIR) Bought (AB) 10k Shares of SUPERNUS PHARMACEUTICALS INC for $6.15 on 3/15</title>
<link href="http://www.insiderinsights.com/company/supn/supernus-pharmaceuticals-inc/id-2392690" ></link>
<id>urn:uuid:c4662b74-998b-1348-5e2d-598fa2b41213</id>
<updated>2013-03-19T17:13:50-04:00</updated>
<summary type="html" ><![CDATA[SUPERNUS PHARMACEUTICALS INC (SUPN). Recent Price: $6.00. Mkt Cap:185.9mm. 10D Vol: 900k]]></summary>
</entry>
<entry>
<title>SUPN: PATRICK GREGORY S (VP,CFO) Bought (AB) 5k Shares of SUPERNUS PHARMACEUTICALS INC for $6.95 on 3/14</title>
<link href="http://www.insiderinsights.com/company/supn/supernus-pharmaceuticals-inc/id-2389964" ></link>
<id>urn:uuid:8f5ec6aa-f244-58f3-1d8f-4bd00bb9c7c7</id>
<updated>2013-03-15T16:16:59-04:00</updated>
<summary type="html" ><![CDATA[SUPERNUS PHARMACEUTICALS INC (SUPN). Recent Price: $6.00. Mkt Cap:185.9mm. 10D Vol: 900k]]></summary>
</entry>
<entry>
<title>SUPN: ORBIMED ADVISORS LLC (BO) Sold (S) 302,183 Shares of SUPERNUS PHARMACEUTICALS INC for $7.52-$7.58 on 2/12-2/13</title>
<link href="http://www.insiderinsights.com/company/supn/supernus-pharmaceuticals-inc/id-2358195" ></link>
<id>urn:uuid:b77f13fc-8283-821a-0584-25c9767609db</id>
<updated>2013-02-14T17:20:40-05:00</updated>
<summary type="html" ><![CDATA[SUPERNUS PHARMACEUTICALS INC (SUPN). Recent Price: $6.00. Mkt Cap:185.9mm. 10D Vol: 900k]]></summary>
</entry>
<entry>
<title>SUPN: BHATT PADMANABH P (VP) Exercised 25k Options (OB) of SUPERNUS PHARMACEUTICALS INC for $0.40 on 2/8, and Kept Them All</title>
<link href="http://www.insiderinsights.com/company/supn/supernus-pharmaceuticals-inc/id-2353542" ></link>
<id>urn:uuid:f7a08683-3b70-b9bc-3f62-6a3bcf341594</id>
<updated>2013-02-12T15:48:32-05:00</updated>
<summary type="html" ><![CDATA[SUPERNUS PHARMACEUTICALS INC (SUPN). Recent Price: $6.00. Mkt Cap:185.9mm. 10D Vol: 900k]]></summary>
</entry>
<entry>
<title>SUPN: VAUGHN VICTOR (VP,SO) Filed a Form 3, Becoming a Registered Insider at SUPERNUS PHARMACEUTICALS INC With Initial Direct Holdings of 4,082</title>
<link href="http://www.insiderinsights.com/company/supn/supernus-pharmaceuticals-inc/id-2350010" ></link>
<id>urn:uuid:9de157b9-95c5-b5b9-cdcd-28880d93d35a</id>
<updated>2013-02-07T19:26:58-05:00</updated>
<summary type="html" ><![CDATA[SUPERNUS PHARMACEUTICALS INC (SUPN). Recent Price: $6.00. Mkt Cap:185.9mm. 10D Vol: 900k]]></summary>
</entry>
<entry>
<title>SUPN: VAUGHN VICTOR (VP,SO) Filed a Form 3, Becoming a Registered Insider at SUPERNUS PHARMACEUTICALS INC With Initial Direct Holdings of 700</title>
<link href="http://www.insiderinsights.com/company/supn/supernus-pharmaceuticals-inc/id-2337080" ></link>
<id>urn:uuid:e14f1bba-8f3a-0417-03d8-893c589bed73</id>
<updated>2013-01-24T13:18:08-05:00</updated>
<summary type="html" ><![CDATA[SUPERNUS PHARMACEUTICALS INC (SUPN). Recent Price: $6.00. Mkt Cap:185.9mm. 10D Vol: 900k]]></summary>
</entry>
<entry>
<title>SUPN: ORBIMED ADVISORS LLC (BO) Sold (S) 297,815 Shares of SUPERNUS PHARMACEUTICALS INC for $6.85-$7.08 on 12/17-12/18</title>
<link href="http://www.insiderinsights.com/company/supn/supernus-pharmaceuticals-inc/id-2315674" ></link>
<id>urn:uuid:ba85f27a-c28f-a114-8ff1-f2f49f56585e</id>
<updated>2012-12-19T21:42:40-05:00</updated>
<summary type="html" ><![CDATA[SUPERNUS PHARMACEUTICALS INC (SUPN). Recent Price: $6.00. Mkt Cap:185.9mm. 10D Vol: 900k]]></summary>
</entry>
<entry>
<title>SUPN: SIEBERT JOHN M (DIR) Exercised 2,188 Options (OB) of SUPERNUS PHARMACEUTICALS INC for $4.24 on 12/14, and Kept Them All</title>
<link href="http://www.insiderinsights.com/company/supn/supernus-pharmaceuticals-inc/id-2312726" ></link>
<id>urn:uuid:0d12c74a-8756-66d4-8ac0-e5c9c3a28d45</id>
<updated>2012-12-17T17:24:39-05:00</updated>
<summary type="html" ><![CDATA[SUPERNUS PHARMACEUTICALS INC (SUPN). Recent Price: $6.00. Mkt Cap:185.9mm. 10D Vol: 900k]]></summary>
</entry>
</feed>